Please login to the form below

Not currently logged in
Email:
Password:

Lilly taps new communications VP

Eli Lilly has named Jeffrey A Winton as its new vice president of communications

Eli Lilly has named Jeffrey A Winton as its new vice president of communications. This will include responsibility for corporate and product communications, employee communications, issues management, and digital and social communications.

Winton will assume his new role at Lilly on October 11. He will serve as a member of the company's Global Corporate Affairs Leadership Team and will report to Bart Peterson, the former mayor of Indianapolis who became Lilly's senior vice president, corporate affairs and communications, in June of last year.

Winton most recently served as managing partner of West Mill Consulting, a strategic communications and PR company that he founded.  Along with its communications services, the consulting firm also offered executive placement, marketing research, and printing and promotions, with a focus on the healthcare, consumer, beauty, travel and financial services sectors.

While at West Mill, Winton served as interim head, communications and public relations for Bayer Healthcare Pharmaceuticals.

Earlier in his career, he held positions including group vice president, global communications at Schering-Plough and vice president, global public relations at Pharmacia.

22nd September 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics